Novo Nordisk implements hiring freeze in certain departments
Novo Nordisk has seen a veritable boom in employee numbers as the company has significantly expanded its business to keep up with demand for diabetes drug Ozempic and obesity drug Wegovy, but now the Danish pharmaceutical giant is introducing a hiring freeze to protect the company culture, Danish business media Finans reported on Wednesday.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novo Nordisk drops plans for Irish factory
For subscribers
Ozempic maker Novo Nordisk has Denmark’s economy hooked
For subscribers